5-((4-Chlorophenethyl)sulfonyl)-1-phenyl-1H-tetrazole

Catalog No. :
ACPYKX275
CAS No. :
1372784-40-1
Molecular Formula :
C15H13ClN4O2S
Molecular Weight :
348.82

IUPAC Name:5-((4-chlorophenethyl)sulfonyl)-1-phenyl-1H-tetrazole

5-((4-Chlorophenethyl)sulfonyl)-1-phenyl-1H-tetrazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg95%$165.00Login to see priceInquiryInquiry
50mg95%$281.00Login to see priceInquiryInquiry
100mg95%$477.00Login to see priceInquiryInquiry
250mg95%$809.00Login to see priceInquiryInquiry
1g95%$2183.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-((4-Chlorophenethyl)sulfonyl)-1-phenyl-1H-tetrazole
IUPAC Name5-((4-chlorophenethyl)sulfonyl)-1-phenyl-1H-tetrazole
MDL No.MFCD21604145
Molecular FormulaC15H13ClN4O2S
Molecular Weight348.82
SMILESO=S(C1=NN=NN1C2=CC=CC=C2)(CCC3=CC=C(Cl)C=C3)=O
InChI KeyNAKVUIUBKDCGGQ-UHFFFAOYSA-N
Synonym5-(4-Chlorophenethylsulfonyl)-1-phenyl-1H-tetrazole;1H-Tetrazole, 5-[[2-(4-chlorophenyl)ethyl]sulfonyl]-1-phenyl-
CAS No.1372784-40-1
PubChem CID57345819

Safety Data

Pictogram
FlammableHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H228-H315-H319
Precautionary Statement(s)
P210-P240-P241-P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P370+P378

Synthetic Route by SureRoute

1. ACPYKX275 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPYKX275 route product structure diagram
    ACPYKX2751372784-40-1
Inquiry

2. ACPYKX275 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDUBE147 route compound structure diagram
    ACDUBE14732327-70-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPYKX275 route product structure diagram
    ACPYKX2751372784-40-1
Inquiry

Comments (0)